Takeda Adds Theravance GI Candidate In Deal Flurry
This article was originally published in PharmAsia News
Executive Summary
In its third licensing deal this week, Takeda is allying with Theravance for the global development of a gastrointestinal agent that will bolster its core portfolio in this area.